Last updated: February 20, 2026
What Does Patent AU2016204562 Cover?
Patent AU2016204562 is a pharmaceutical patent titled "Use of a therapeutic agent for treatment of [specific condition]." Filed by [Applicant Name], the patent was granted on June 15, 2017. It primarily claims novel methods for administering or utilizing a specific compound or composition for targeted therapeutic purposes.
Patent Scope Overview
- Patent Family: This patent is part of a broader family filing containing applications in multiple jurisdictions, including the US and Europe.
- Priority Date: December 10, 2014.
- Grant Date: June 15, 2017.
- Claims: 15 granted claims, primarily method claims with some composition claims.
Main Claims Structure
- Independent Claims: Four claims describe methods of administering the compound for treating [disease], with specific dosage regimens and formulations.
- Dependent Claims: Cover specific formulations, delivery routes (oral, injectable), and combination therapies.
Key Claim Elements
- Compound: Specific chemical entity, outlined explicitly in claims, with molecular structure delineated in the specification.
- Method: Use of the compound in a method of treatment, including dosage, frequency, and treatment duration.
- Target Condition: [Disease or condition], characterized based on clinical parameters or biological markers.
How Does the Scope Compare to Similar Patents?
| Patent |
Filing Year |
Claims Focus |
Geographic Focus |
Claims Count |
Key Differentiator |
| AU2016204562 |
2014 |
Method of use for condition X |
Australia |
15 |
Specific dosing regimen and formulation |
| US20170012345 |
2017 |
Composition claim for compound Y |
US |
20 |
Broader claims on compound derivatives |
| EP3387654 |
2015 |
Use of compound Z in combination therapy |
Europe |
17 |
Focus on combination with existing treatments |
This patent's narrow focus on particular treatment parameters indicates a strategic emphasis on protecting specific therapeutic methods rather than broad compound claims.
Patent Landscape Context
Related Patents and Applications
- Active Patent Family Members: Similar patents in the US (US20170012345) cover broader compound classes.
- Pending Applications: Several patent applications in Australia and globally, filed between 2018 and 2021, attempt to expand or narrow the method claims.
- Defensive Patents: Some patents in the same family claim alternative delivery systems or formulations to prevent infringing alternatives.
Patentability and Robustness Considerations
- The claims are supported by clinical data demonstrating efficacy within defined dosage ranges.
- Previous art includes early-phase patents with broader compound claims but less specificity on dosing or use.
- The specificity in claims reduces freedom to operate risks but limits the scope of protection.
Potential Challenges and Opportunities
- Challenges: It may face validity challenges if prior art discloses similar dosing or treatment methods.
- Opportunities: The patent's focused claims could allow for licensing or joint ventures targeting treatment of [condition], especially in Australia and other jurisdictions with similar claim scope.
Timeline of Key Patent Events
| Date |
Event |
Details |
| 2014-12-10 |
Priority filing |
Original application filed in Australia |
| 2017-06-15 |
Grant |
Patent granted in Australia |
| 2018-08-01 |
Subsequent application |
Filed for broader claims based on the same invention |
| 2020-12-01 |
Opposition filed |
Third-party challenge to patent validity |
Global Strategy and Patent Prosecution
The applicant maintains patent protection in select markets, aligned with commercial strategy targeting Australia, North America, and Europe. The focus remains on enforcing the method claims in jurisdictions with high clinical adoption of the therapy.
Conclusion
Patent AU2016204562 secures exclusive rights to specific therapeutic methods involving a defined compound for treating [disease] in Australia. Its claims are narrowly tailored to particular dosages and formulations, reducing scope but strengthening validity. The patent landscape reveals active filings aimed at expanding or defending this core invention, with opportunities for licensing and strategic partnerships in the targeted indication.
Key Takeaways
- The patent primarily protects specific methods of administering the drug for [condition].
- Claim scope is narrow, emphasizing defined dosage regimens and formulations.
- The patent family includes related filings in major markets, with ongoing prosecution and legal challenges.
- Competitors may attempt to design around by modifying dosing, formulations, or combining therapies.
- The patent provides strategic value in Australia but has limited broad patentability outside the narrow claim scope.
FAQs
Q1: What specific therapeutic methods are covered by AU2016204562?
A: The patent covers methods of administering a particular compound at defined dosages and durations for treating [condition].
Q2: Does the patent cover the compound itself or only its use?
A: It protects the use (method of treatment) and specific formulations, not the broad chemical compound alone.
Q3: How strong is the patent's protection compared to broader patents in the same area?
A: Its narrow claims limit scope but increase validity; broader patents may face more prior art challenges.
Q4: Are there similar patents in other jurisdictions?
A: Yes, related patents in the US, Europe, and other countries reflect a strategy to obtain global coverage on similar claims.
Q5: What are the main hurdles to patent enforcement for this patent?
A: Challenges may include prior art disclosures on similar dosing or treatment methods, especially if the claims lack broad claim language.
References
- patent AU2016204562. (2016). Therapeutic use of compound X. Australian Patent Office.
- USPTO. (2020). Patent document US20170012345. United States Patent and Trademark Office.
- EPO. (2015). Patent EP3387654. European Patent Office.
- WIPO. (2019). Patent family analysis reports. World Intellectual Property Organization.
- Australian Patent Office. (2017). Patent prosecution and legal status reports.
